CurcumSorb (formerly Meriva®) delivers highly bioavailable curcumin, providing maximal support for healthy inflammatory balance, as well as musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.

CurcumSorb is a patented curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes.

This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with CurcumSorb than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg CurcumSorb were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg Meriva® per day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.

2–6 capsules per day, in divided doses, between meals.